← Back to all trials
Completed
NCT05204030
Hashtag HPV: HPV Vaccine Twitter Education Program
Conditions: Human Papilloma Virus, Vaccine-Preventable Diseases
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: Yes
Phase: NA
Enrollment: 28
Sponsor: University of Arkansas, Fayetteville
Location: University of Arkansas Fayetteville Arkansas
Summary
Parents use social media as an important parenting tool and source for health information. Using social media data to examine public opinion has had an early impact in public health and in cancer control and prevention efforts, including about the human papillomavirus (HPV) vaccine. A next step in this area of research is to develop and share messages on social media with parents to help inform and educate them about the HPV vaccine - ultimately assisting them with their decision to vaccinate their child. This study will evaluate the efficacy of social media messages through Twitter, using a randomized controlled trial to determine what types of messages resonate with parents. The investigators will examine differences between two types of messages - narrative messages (i.e., stories) and non-narrative messages (i.e., numbers and facts).
Eligibility Criteria
Inclusion Criteria: The study population includes parents who have children ages 9-14. All participants will be 18 years of age or older, and we will specifically target parents ages 25 and older. Eligibility for enrollment in the study will be limited to the following criteria:
1. Adults 18 years of age and older;
2. Utilizes Twitter, a social media platform;
3. Has a child aged 9-14;
4. Child has not started the 2-dose HPV vaccination series;
5. Has no child who has completed any dose HPV vaccination series;
6. Has a well-care visit scheduled for their child before December, 2022.
Exclusion Criteria:
1. Any adult who does not have a child 9-14 years of age;
2. Any adult who does not indicate some level of participation in Twitter;
3. Any adults who indicates a high level of anti-vaccine sentiment (assessed by vaccine hesitancy questions asked in the screener).
Source: ClinicalTrials.gov (NCT05204030). StuddyBuddy aggregates publicly available trial information.